History of depression and smoking cessation outcome: A meta-analysis.
Journal of Consulting and Clinical PsychologyPublished 1 January 2003
Brian Hitsman, Belinda Borrelli, Dennis E. McChargue, Bonnie Spring, Raymond Niaura
Citations255
SJR quartileQ1
SJR score2.23
SNIP2.00
Generate an AI Snapshot to get a quick, structured summary of this paper.
Study Snapshot
ObjectiveStudy objective
MethodsResearch methodology
PopulationPopulation studied
Sample sizeSample sizes
OutcomesStudy outcomes here
ResultsStudy results comes here
LimitationsResearch study limitations comes here
A concise AI-generated summary of the paper will appear here once you click Generate AI Snapshot.
TL;DR
Lifetime history of major depression does not appear to be an independent risk factor for cessation failure in smoking cessation treatment.
Abstract
The authors conducted a meta-analysis of published studies to (a) evaluate the premise that a history of major depression is associated with failure to quit smoking and (b) identify factors that moderate the relationship between history of depression and cessation outcome. Fifteen studies met the selection requirements and were coded for various study methodology and treatment characteristics. DSTAT was used to calculate individual study effect sizes, determine the mean effect size across studies, and test for moderator effects. No differences in either short-term ( or = 6 months) were observed between smokers positive versus negative for history of depression. Lifetime history of major depression does not appear to be an independent risk factor for cessation failure in smoking cessation treatment.
Keywords
Medicine
Journal of Educational StatisticsStatistical Methods for Meta-Analysis
10,479 Citations1988Stanley Wasserman, Larry V. Hedges +1 more
JAMACross-National Epidemiology of Major Depression and Bipolar Disorder
2,232 Citations1996Myrna M. Weissman
There are striking similarities across countries in patterns of major depression and of bipolar disorder and the differences in rates for major depression across countries suggest that cultural differences or different risk factors affect the expression of the disorder.
Journal of Abnormal PsychologyVulnerability: A new view of schizophrenia.
1,951 Citations1977Joseph Zubin, Bonnie Spring
JAMASmoking, Smoking Cessation, and Major Depression
1,189 Citations1990Alexander H. Glassman
The association between cigarette smoking and major depression was not ubiquitous across all psychiatric diagnoses, and gender differences in rates of smoking and of smoking cessation observed in the larger population were not evident among the depressed group.
Nicotine & Tobacco ResearchMeasures of abstinence in clinical trials: issues and recommendations
1,072 Citations2003John R. Hughes, Josue Keely +4 more
A workgroup formed by the Society for Research on Nicotine and Tobacco reviewed the literature on abstinence measures used in trials of smoking cessation interventions and recommended that trials report multiple measures of abstinence.
JAMADepression and the Dynamics of Smoking
880 Citations1990Robert F. Anda
Depressed smokers were 40% less likely to have quit compared with nondepressed smokers and adjusted for amount smoked, sex, age, and educational attainment by means of a Cox proportional hazards model found that depression plays an important role in the dynamics of cigarette smoking in the United States.
American Journal of PsychiatryCigarette smoking: implications for psychiatric illness
732 Citations1993Alexander H. Glassman
It is the view of this author that both cigarette smoking and smoking cessation are highly relevant to the clinical psychiatrist in the care of patients and that they are potentially a source of important insights into psychopathology.
Psychological MethodsThe power of statistical tests in meta-analysis.
674 Citations2001Larry V. Hedges, Terri Pigott
Archives of General PsychiatryMajor Depression and Stages of Smoking
644 Citations1998Naomi Breslau, Edward L. Peterson +3 more
JAMAHeavy Smokers, Smoking Cessation, and Clonidine
480 Citations1988Alexander H. Glassman
Findings are highly suggestive of an important role of clonidine in smoking cessation, and warrant further studies to establish the long-term efficacy of this drug and to replicate the association between nicotine dependence and depression.
Archives of General PsychiatryNicotine Dependence and Major Depression
452 Citations1993Naomi Breslau
The prospective data suggest that the association between nicotine dependence and MDD might be either causal, with influences flowing in both directions, or, more probably, noncausal, reflecting the effects of common factors that predispose to both disorders.
Archives of General PsychiatryNortriptyline and Cognitive-Behavioral Therapy in the Treatment of Cigarette Smoking
393 Citations1998Sharon M. Hall, Victor I. Reus +6 more
Nortriptyline is a promising adjunct for smoking cessation and increases in negative affect after quitting smoking are attenuated by nortripty Line, independent of depression history.
The LancetSmoking cessation and the course of major depression: a follow-up study
374 Citations2001Alexander H. Glassman, Lirio S. Covey +2 more
Smokers with a history of depression who abstain from smoking are at significantly increased risk of developing a new episode of major depression, and this risk remains high for at least 6 months.
Comprehensive PsychiatryDepression and depressive symptoms in smoking cessation
336 Citations1990Lirio S. Covey, Alexander H. Glassman +1 more
Interventions designed to prevent dysphoric symptoms during the acute withdrawal period may improve smoking cessation outcome for smokers with a history of major depression.
The British Journal of PsychiatryEfficacy of bupropion for smoking cessation in smokers with a former history of major depression or alcoholism∗
271 Citations1999Kyla Hayford, Christi A. Patten +7 more
Bupropion is efficacious for smoking cessation independently of a former history of major depression or alcoholism, and increases in depressive symptoms during an initial period of abstinence are associated with a return to smoking.
Journal of Consulting and Clinical PsychologyCognitive-behavioral intervention increases abstinence rates for depressive-history smokers.
252 Citations1994Sharon M. Hall, Ricardo F. Muñoz +1 more
Journal of Consulting and Clinical PsychologyCognitive–behavioral treatment for depression in smoking cessation.
230 Citations2001Richard A. Brown, Christopher W. Kahler +7 more
Results suggest that CBT-D provides specific benefits for some, but not all, smokers with a history of MDD, and that smokers with recurrent MDD and heavy smokers who received CBt-D were significantly more likely to be abstinent than those receiving ST.
Addictive BehaviorsInvestigation of mechanisms linking depressed mood to nicotine dependence
215 Citations1996Caryn Lerman, Janet Audrain +5 more
The present study examined the cognitive-behavioral linkages between depressed mood and level of nicotine dependence in smokers seeking smoking cessation treatment and suggested that negative affect reduction smoking and stimulation smoking are sequential mediators of the depression-nicotine dependence relationship.
Psychology of Addictive BehaviorsSymptoms of depression and survival experience among three samples of smokers trying to quit.
207 Citations2001Raymond Niaura, Dana M. Britt +4 more
Results were robust and uniformly clear, indicating that low levels of depressive symptoms assessed at baseline predict time to 1st cigarette smoked after attempted quitting.
Archives of Internal MedicineA Randomized Trial of Nortriptyline for Smoking Cessation
194 Citations1998Allan V. Prochazka, Michael Weaver +4 more
Nortriptyline hydrochloride led to an increased short-term cessation rate compared with placebo and there were significant, but relatively small, reductions in withdrawal symptoms.
Clinical Pharmacology & TherapeuticsSmoking cessation, clonidine, and vulnerability to nicotine among dependent smokers
170 Citations1993Alexander H. Glassman, Lirio S. Covey +5 more
This study examines the efficacy of clonidine in smoking cessation and the influence of gender, history of major depression, and measures of nicotine dependence.
Journal of Consulting and Clinical PsychologyMood management and nicotine gum in smoking treatment: A therapeutic contact and placebo-controlled study.
165 Citations1996Sharon M. Hall, Ricardo F. Muñoz +3 more
Nicotine & Tobacco ResearchThe increasing recalcitrance of smokers in clinical trials
129 Citations2000Thomas H. Brandon Jennifer E. Irvin
The efficacy of clinical trials--with treatment held constant--appears to be declining, and one possible cause is the increasing recalcitrance of those individuals who continue to smoke despite social, regulatory, and medical pressures to quit.
American Journal of Community PsychologyMood Management Mail Intervention Increases Abstinence Rates for Spanish‐Speaking Latino Smokers
117 Citations1997Ricardo F. Muñoz, Bárbara VanOss Marín +2 more
It is concluded that the mood management mail intervention substantially increases abstinence rates, especially for those with a history of major depressive episodes.
Journal of Addictive DiseasesNaltrexone Effects on Short-Term and Long-Term Smoking Cessation
112 Citations1999Lirio S. Covey, Alexander H. Glassman +1 more
The results provide, at best, mild promise for naltrexone as a smoking cessation drug and provide another instance of a differential response to nicotine dependence treatment according to gender and depression history.
The Journal of Clinical PsychiatryDevelopment of Major Depressive Disorder During Smoking-Cessation Treatment
105 Citations1996Christopher R. Murphy, David B. Abrams
It is suggested that a subset of smokers may be at risk for developing major depressive disorder after smoking cessation, and those who developed MDD after treatment scored significantly higher on measures of depressed mood at baseline than those who did not developMDD after smoking-cessation treatment.
JAMAHeavy smokers, smoking cessation, and clonidine. Results of a double-blind, randomized trial
104 Citations1988Alexander H. Glassman
Nicotine & Tobacco ResearchHistory and symptoms of depression among smokers during a self-initiated quit attempt
101 Citations1999Raymond Niaura, Dana M. Britt +4 more
Results indicated that prior to quitting, smokers with a history of depression smoked to reduce negative affect, in response to craving, and in social situations, and positive history smokers scored higher on the Center for Epidemiological Studies Depression Scale than did smokers without such a history.
American Journal of PsychiatryEffect of history of alcoholism or major depression on smoking cessation
100 Citations1993Lirio S. Covey, A H Glassman +2 more
The authors examined the influence of a history of alcoholism or major depression on smoking cessation for 220 subjects and found the success rate of recovering alcoholics was comparable to that of nonalcoholics, comorbidity of alcoholism and major depression exerted a detrimental effect, and smoking cessation did not precipitate an alcoholic relapse.
Nicotine & Tobacco ResearchMeasures of abstinence in clinical trials: issues and recommendations
98 Citations2003John Hughes, John Hughes +4 more
AddictionThe future of smoking cessation therapy in the United States
88 Citations1996John R. Hughes
Six trends that are likely to influence the future content, format, delivery and reach of smoking cessation therapy in the United States are discussed and smoking cessation therapies become reimbursable on par with other drug dependencies.
Journal of Consulting and Clinical PsychologyNicotine patch and paroxetine for smoking cessation.
88 Citations2000Joel D. Killen, Stephen P. Fortmann +6 more
The combined treatment was more effective in reducing both craving and depression symptoms associated with smoking cessation and paroxetine may add value to the current standard of care in excess of potential risk.
Clinical Psychology ReviewAging and depression: Vulnerability and stress across adulthood
84 Citations1997Michele J. Karel
This review of the relationship of age to depression shows that the study of psychopathology and adult development can inform each other and suggest a changing salience of risk factors for depression from young adulthood through old age as well as to cohort differences in risk for depression.
NeuropsychopharmacologyThe Effects of Transdermal Nicotine Therapy for Smoking Cessation on Depressive Symptoms in Patients with Major Depression
62 Citations2001Haraldur S. Thorsteinsson
There was little evidence for effects of active nicotine patches on measures of mood (HRSD, BDI, POMS) or withdrawal symptoms among subjects that remained abstinent throughout the study (N = 24).
Experimental and Clinical PsychopharmacologyDo men outperform women in smoking cessation trials?: Maybe, but not by much.
51 Citations2002Joel D. Killen, Stephen P. Fortmann +2 more
There may be little value to diverting research funds from efforts to develop more effective treatments for both men and women to efforts to explain a very small gender effect associated with existing treatments, but it may be appropriate to make gender comparisons for new therapies for nicotine dependence.
Psychotherapy and PsychosomaticsComorbidity, Smoking Behavior and Treatment Outcome
42 Citations2000Nancy J. Keuthen, Raymond Niaura +7 more
High prevalence rates of lifetime psychiatric illness and substance use disorders are reported for chronic smokers, and subsyndromal psychiatric symptoms may play a role in smoking behavior in combination with diagnosable disorders.
PubMedDouble-blind fluoxetine in depressed alcoholic smokers.
38 Citations1997Jack R. Cornelius, Ihsan M. Salloum +6 more
Fluoxetine has the potential for treating the smoking and drinking behaviors of depressed alcoholic smokers, and the change in smoking was significantly associated with a change in drinking.
Addictive BehaviorsHistory of depression and subsyndromal depression in women smokers
33 Citations1999Belinda Borrelli, Bess H. Marcus +4 more
SubD does not appear to be on a continuum with Non-Depressed and MDD groups, but rather warrants further investigation as a discrete subset of smokers.
Journal of Clinical PsychopharmacologyFluoxetine Versus Placebo to Decrease the Smoking of Depressed Alcoholic Patients
29 Citations1999Jack R. Cornelius, Kenneth A. Perkins +3 more
The LancetStopping smoking: a hazard for people with a history of major depression?
20 Citations2001Raymond Niaura, David B. Abrams
CNS DrugsSmoking Cessation in Individuals with Depression
17 Citations1999Taru Kinnunen, Lauri Henning +1 more
The efficacy, suitability and other treatment issues involved in using nicotine replacement therapy, antidepressant treatment and cognitive-behavioural interventions to help depressed smokers quit smoking are discussed.